Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1 Lymphoid 1

Conditions

Interventions

Cyclophosphamide 345 Rituximab 309 Vincristine 160 Doxorubicin 157 venetoclax 156 fludarabine 153 Specimen Handling 152 Prednisone 152 Biopsy 122 obinutuzumab 117 Magnetic Resonance Spectroscopy 117 Lenalidomide 110 Dexamethasone 106 Cytarabine 100 ibrutinib 96 Etoposide 94 fludarabine phosphate 87 Methotrexate 86 acalabrutinib 79 zanubrutinib 73 Bendamustine Hydrochloride 73 pembrolizumab 63 blinatumomab 63 CT-P10 61 Gemcitabine 52 glofitamab 45 Nivolumab 45 Calcium Dobesilate 45 Mercaptopurine 44 prednylidene 43

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

BNT162 Vaccine × Lymphoid × 1 year × Clear all

NCT05170399 2026-02-05

Vaccine Responses in Patients With B Cell Malignancies

National Institutes of Health Clinical Center (CC)

Phase 4 Recruiting

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡